A new approach to drug design can deliver medicine directly to the gut in mice at significantly lower doses than current inflammatory bowel disease treatments. The proof-of-concept study introduced a ...

Of the total ER visits, nearly 70% involved GI issues, 15% of which led to hospitalization, according to a new study.

Researchers say GlycoCaging may offer a route to rescue promising drug candidates that currently show unacceptable systemic ...

A new clinical trial shows the immunotherapy drug dostarlimab may eliminate the need for surgery and chemotherapy in certain ...

The European Medicines Agency has recommended marketing approval for Alyftrek for cystic fibrosis and Attrogy for a form of ...

A new study analyzed how often people develop severe side effects after taking semaglutide — known by brand names Ozempic and ...

An analysis of emergency visits related to the active ingredient in drugs like Ozempic and Wegovy has exposed a surprising ...

In a groundbreaking cancer study, researchers found that immunotherapy drugs alone can treat gastrointestinal tumours.For as ...

Patients with some gastrointestinal tumors were able to be treated with immunotherapy drugs alone and avoid surgery, ...

Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found ...

HonorHealth Research Institute's new downtown Phoenix laboratory has produced its first study, centered on a promising new ...